tiprankstipranks
Trending News
More News >
Unicharm (UNICY)
OTHER OTC:UNICY

Unicharm (UNICY) AI Stock Analysis

Compare
18 Followers

Top Page

UNICY

Unicharm

(OTC:UNICY)

Select Model
Select Model
Select Model
Neutral 57 (OpenAI - 4o)
Rating:57Neutral
Price Target:
$3.00
▲(4.53% Upside)
Unicharm's stock score is primarily influenced by its stable financial performance, despite concerns over declining revenue and cash flow. The technical analysis indicates bearish momentum, which negatively impacts the score. The valuation is reasonable, but the lack of a dividend yield is a drawback for some investors.
Positive Factors
Profitability Margins
Strong profitability margins indicate efficient cost management and pricing power, supporting long-term financial stability and competitiveness.
Low Leverage
Minimal leverage enhances financial flexibility and reduces risk, allowing Unicharm to invest in growth opportunities without excessive debt burden.
Market Expansion
International market expansion diversifies revenue streams and reduces dependence on domestic markets, supporting long-term growth potential.
Negative Factors
Declining Revenue
A significant revenue decline suggests potential challenges in market demand or competitive pressures, posing risks to future growth and profitability.
Free Cash Flow Decline
Declining free cash flow growth can limit investment capacity and affect the company's ability to fund operations and strategic initiatives.
Revenue Growth Concerns
Concerns about revenue growth highlight potential structural market challenges that could impact long-term business sustainability.

Unicharm (UNICY) vs. SPDR S&P 500 ETF (SPY)

Unicharm Business Overview & Revenue Model

Company DescriptionUnicharm Corporation (UNICY) is a leading Japanese consumer goods company specializing in the production and distribution of hygiene products. Established in 1961, Unicharm operates primarily in the sectors of personal care, pet care, and health care. Its core product offerings include disposable diapers, feminine hygiene products, adult incontinence products, and pet hygiene products. The company is known for its innovation in product design and technology, providing high-quality, user-friendly solutions for its customers across various markets.
How the Company Makes MoneyUnicharm generates revenue through the sale of its extensive range of hygiene products across multiple segments. The company's primary revenue streams include sales of disposable diapers, which are a significant part of its business, and feminine hygiene products, which also contribute notably to earnings. Additionally, revenue is derived from adult incontinence products and pet care items. Unicharm leverages a combination of direct-to-consumer sales, retail partnerships, and e-commerce channels to distribute its products. Strategic partnerships with retailers and distributors enhance its market presence, while ongoing investments in research and development allow for continual product innovation, which helps maintain its competitive edge in the market. Furthermore, Unicharm has expanded into international markets, capitalizing on growth opportunities in regions such as Asia and beyond, which also contributes to its revenue growth.

Unicharm Earnings Call Summary

Earnings Call Date:Aug 05, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Feb 12, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mixed picture with notable achievements in Japan and North America, and strategic shareholder returns. However, significant challenges were highlighted, particularly in Asia, with declining sales and profitability leading to a downward revision of the earnings forecast.
Q2-2025 Updates
Positive Updates
Japan's Record Performance
Japan achieved a 4.1% increase in net sales and a 2.9% increase in core operating income, the highest results ever recorded, driven by new product success and an improved sales mix in wellness and pet care.
Strong Performance in the Middle East & North America
The Middle East and North America saw strong growth, with North America pet care sales increasing by 14.6% and income by 25.3%. In the Middle East, baby and feminine care products have seen strong sales growth.
Dividend Increase and Share Buyback
The company plans to increase the annual dividend by JPY3.3 per share to JPY18 per share, marking the 24th consecutive year of dividend increases. An additional JPY10 billion of treasury stock will be repurchased.
Insurance Income Boost
Unicharm received JPY5.3 billion in insurance income in India, contributing to an increase in interim income attributable to owners of the parent company.
Negative Updates
Sales and Core Operating Income Decline
Consolidated sales fell by 4.8% to 464.2 billion, and core operating income decreased by 22% to JPY57 billion, primarily due to strong performance in the previous year and reputational incidents in China.
Challenges in Asia
Net sales in Asia declined 14.5% and core operating income fell 69.4%, driven by challenges in China, Indonesia, and Thailand, including reputational damage and competitive pressures.
Downward Revision of Earnings Forecast
The earnings forecast for the fiscal year was revised downward due to slower-than-expected recovery in Asia and the impact of rumors affecting sales in China.
Increased Costs Affecting Profitability
Increased SG&A expenses, logistics, and strategic marketing investments in Asia led to a JPY16.1 billion decrease in core operating income.
Company Guidance
In the call, Unicharm Corporation reported a 4.8% decline in sales to JPY464.2 billion and a 22% decrease in core operating income to JPY57 billion for the second quarter of fiscal year 2025. This decline was primarily attributed to a reaction to the previous year's record-high profits and reputational issues in the feminine care segment in China. The Asian market faced competitive pressures, and strategic marketing and sales promotions further impacted earnings. However, interim income attributable to the parent company increased due to JPY5.3 billion in insurance income from India and the utilization of tax loss carryforwards. The Japan business achieved a 4.1% increase in net sales and a 2.9% increase in core operating income, marking its highest results ever recorded. Despite challenges in Asia, signs of recovery are emerging, particularly in Vietnam, and strategic investments in growth channels are expected to yield positive results from the third quarter onward. Additionally, the fiscal year forecast was revised downward due to slower recovery in Asia, while regions like Japan, North America, and the Middle East performed better than expected. The company is also committed to shareholder returns, targeting a total return ratio of 50% or more.

Unicharm Financial Statement Overview

Summary
Unicharm exhibits strong profitability margins and low leverage, indicating financial stability. However, the significant decline in revenue and free cash flow growth raises concerns about future growth prospects.
Income Statement
65
Positive
Unicharm's income statement shows a mixed performance. The TTM data indicates a significant revenue decline of 24.11%, which is concerning. However, the company maintains a healthy gross profit margin of 38.45% and a net profit margin of 8.64%. The EBIT and EBITDA margins are also solid at 13.67% and 18.60%, respectively. Despite the revenue drop, profitability remains stable, but the declining revenue trend poses a risk.
Balance Sheet
75
Positive
The balance sheet reflects a strong financial position with a low debt-to-equity ratio of 0.0189, indicating minimal leverage. The return on equity is decent at 10.85%, showcasing effective use of equity to generate profits. The equity ratio is robust, suggesting a solid capital structure. Overall, the balance sheet indicates financial stability and low risk.
Cash Flow
60
Neutral
Cash flow analysis reveals some challenges. The free cash flow growth rate has declined by 28.51% in the TTM period, which is a concern. However, the operating cash flow to net income ratio is reasonable at 0.48, and the free cash flow to net income ratio is 0.74, indicating that the company generates sufficient cash relative to its net income. While cash flow generation is adequate, the declining trend in free cash flow growth needs attention.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue732.66B988.98B941.79B898.02B782.72B727.48B
Gross Profit376.82B389.91B351.53B328.60B313.64B292.61B
EBITDA133.09B191.02B180.56B161.16B160.80B147.56B
Net Income83.01B81.84B86.05B67.61B72.75B52.34B
Balance Sheet
Total Assets1.18T1.24T1.13T1.05T987.65B893.41B
Cash, Cash Equivalents and Short-Term Investments311.57B368.75B253.77B307.60B307.30B297.11B
Total Debt14.48B26.85B28.57B27.02B38.31B33.18B
Total Liabilities2.15B366.26B345.38B340.61B352.22B330.76B
Stockholders Equity767.42B773.06B695.72B618.88B557.64B493.00B
Cash Flow
Free Cash Flow65.65B97.77B124.00B59.27B70.58B114.75B
Operating Cash Flow89.45B137.10B162.41B92.22B105.25B150.25B
Investing Cash Flow-3.78B-73.84B-67.53B-7.14B-79.84B-41.70B
Financing Cash Flow-44.69B-66.79B-67.01B-61.65B-45.18B-35.24B

Unicharm Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.87
Price Trends
50DMA
3.04
Negative
100DMA
3.19
Negative
200DMA
3.58
Negative
Market Momentum
MACD
-0.05
Negative
RSI
40.22
Neutral
STOCH
14.09
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UNICY, the sentiment is Negative. The current price of 2.87 is below the 20-day moving average (MA) of 2.89, below the 50-day MA of 3.04, and below the 200-day MA of 3.58, indicating a bearish trend. The MACD of -0.05 indicates Negative momentum. The RSI at 40.22 is Neutral, neither overbought nor oversold. The STOCH value of 14.09 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for UNICY.

Unicharm Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$142.85B23.8528.36%3.74%-0.30%-14.60%
72
Outperform
$20.23B26.8418.59%1.38%1.45%42.04%
69
Neutral
$333.43B20.9031.90%2.92%1.23%17.97%
63
Neutral
$63.71B22.40450.35%2.67%-0.05%2.49%
63
Neutral
$33.11B16.96136.87%5.03%-10.04%-23.41%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
57
Neutral
$10.44B18.0211.28%-0.81%-0.63%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
UNICY
Unicharm
2.85
-1.24
-30.32%
CHD
Church & Dwight
85.25
-20.15
-19.12%
CL
Colgate-Palmolive
79.93
-10.26
-11.38%
KMB
Kimberly Clark
100.11
-27.78
-21.72%
PG
Procter & Gamble
143.18
-22.60
-13.63%
UL
Unilever
65.73
6.15
10.32%

Unicharm Corporate Events

Unicharm Corporation Reports Mixed Financial Results for H1 2025
Aug 6, 2025

Unicharm Corporation is a leading Japanese company specializing in personal care, pet care, and other hygiene-related products, with a strong presence in both domestic and international markets.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 18, 2025